HomeAbout UsPress RoomInvestor RelationsCareersContact Us Explore The Thomson Corporation
The Thomson Corporation
Financial
Healthcare
Learning
Legal
News and Business Info
Scientific
Tax and Accounting
Thomson BioWorld
Home : BioWorld Top 25 Biotechnology Drugs Report  

BioWorld Top 25 Biotechnology Drugs Report

 

"The multi-billion dollar biotechnology drug market has emerged from the shadow of the pharmaceutical industry and merits critical analysis of its leading products. This new report from BioWorld Today profiles and examines the drugs driving this market and attracting
investor attention."


The BioWorld Top 25 Biotechnology Drugs Report is the first report of its kind: It delivers a comprehensive and in-depth analysis of the top 25 biotech drugs, as ranked by revenue, in one single report, and provides you with the knowledge you need to take quick action on vital business decisions related to the biotech drug market.

An attempt to research this information can lead you in many different directions, but with the BioWorld Top 25 Biotechnology Drugs Report, you can access extensive profiles of each of the top 25 leading products. Analysis includes:
 

  • Rank
  • Indications
  • Disease description & statistics
  • Chronology of development through approval
  • Patent protection dates
  • Competing drugs on the market and in development
  • Secondary indications in development
  • Partnerships involved in the drug
  • Projection of the drug's short-term future
     

These drug profiles span a wide range of disease indications, including cancer, diabetes, infectious diseases, and blood disorders, and include pertinent information for many with a stake in the biotech drug market, such as biotechnology companies, pharmaceutical companies, investors, analysts, attorneys, PR firms and researchers.

Chart and table-focused sections of the report also lend themselves nicely as supporting data for company reports and presentations, such as:
 

  • All biotech drugs approved over the last 20 years
  • Overall values of biotech and pharma markets
  • Revenue generated by the top 25 biotech drugs
  • What promising biotech drugs are on the horizon
     

With 192 pages of profiles, analysis, tables, and charts, the BioWorld Top 25 Biotechnology Drugs Report is the perfect resource for preparing business plans and marketing strategies, and deepening your understanding of the biotech drug market.

We urge you to order your copy of the BioWorld Top 25 Biotechnology Drugs Report today by submitting the form below. Each report is only $499 (plus $9.95 shipping & handling).

If you'd rather call in your order for rush delivery, please dial 1-800-688-2421 or 1-404-262-5476 and mention priority code #EM/51104.


Online Ordering Options:

1) Click here to order by credit card using our secure online order form.

or

2) To be billed, submit the form below. Please note that orders not prepaid by credit card will incur a $10 billing fee.
First Name *
Last Name *
Title *
Company *
Address *
City *
State/Province *
ZIP/Postal code *
Country *
Telephone *
FAX
E-mail *


* denotes required field


All customers who do not prepay by credit card will be contacted by an
account representative to confirm and verify order information. Non-credit
card orders also will incur a $10 billing fee.

 

 
BioWorld Home   |   About BioWorld   |   Contact Us
Copyright Notices   |   Terms of Use   |   Privacy Statement